Company Directory / research
PrivateFor profitresearchWorcester, United States
Nex Eye
Nex Eye is a start-up that develops first-in-class antibodies targeting refractory factors of immuno-oncology drugs.
- Founded
- 2021 5 years ago
- Staff
- - band, as listed
- Followers
- - on LinkedIn
- Funding
- $26B as listed, currency not stated
Set against six million companies
Size
Size not listed
Age
5 years old.
Reach
Website ranked #2,445,062 in the world for traffic, about 8k visits a month.
What it does
MedicalOncologyPharmaceutical
Funding, as listed
$26B currency not stated
- Rounds2
- LatestSeries a, Oct 2022
- Investors11
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Nex Eye, field by field. Contact details are held but never shown.
The company
- Name
- Nex Eye
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Industry
- research
- Categories
- Medical, Oncology, Pharmaceutical
Where
- City
- Worcester
- Country
- United States
- Markets
- Asia-Pacific (APAC)
Size and reach
- Web traffic rank
- #2,445,062
- Monthly web visits
- 7,662
Funding, as listed
- Total
- 26,000,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series a
- Latest round date
- Oct 2022
- Investors
- 11
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.